Aristeia Capital’s GeneDx Holdings Warrant WGSWW Stock Holding History

Aristeia Capital’s Portfolio WGSWW Stock Details WGSWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-53,467	Closed	-$35K	–	716
2022 Q1	$35K	Sell	53,467 -17,557	-25%	-$12.1K	﹤0.01%	677
2021 Q4	$69K	Hold	71,024	–	–	﹤0.01%	590
2021 Q3	$152K	Buy	+71,024	New	+$233K	﹤0.01%	490

Other funds holding WGSWW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

Aristeia Capital's WGSWW Position: Q2 2022 in Review

Aristeia Capital sold out of GeneDx Holdings Warrant (WGSWW) in Q2 2022, closing a stake of 53,467 shares — an estimated $35K sold.

Aristeia Capital first reported a position in WGSWW in Q3 2021 and held it in 3 quarters. The position peaked at $152K in Q3 2021. 27 funds tracked by Wall St. Rank hold WGSWW as of Q2 2022.

Aristeia Capital reported no remaining GeneDx Holdings Warrant position as of Q2 2022 after selling out during the quarter.
Aristeia Capital sold 53,467 GeneDx Holdings Warrant shares in Q2 2022, an estimated $35K.
Aristeia Capital first reported a position in GeneDx Holdings Warrant in Q3 2021 and held it in 3 quarters.
Aristeia Capital's GeneDx Holdings Warrant position peaked at $152K in Q3 2021.
27 funds tracked by Wall St. Rank held GeneDx Holdings Warrant as of Q2 2022.

Based on Aristeia Capital's 13F filing for Q2 2022, filed 16 Aug 2022.